“…As a result of the cardiovascular morbidity associated with ECT (2,3), a wide variety of drugs have been administered in an effort to minimize the acute hemodynamic changes (2). Studies involving trimethaphan (4), nitroprusside (5), nitroglycerine (6), alfentanil (7), clonidine (8), 1 propranolol (9), 1 esmolol (10), labetalol (11)(12)(13), nicardipine (13), urapidil (14), dexmedetomidine (15), and diltiazem (16) have reported varying degrees of success in attenuating the acute hyperdynamic response associated with ECT.…”